Gland Pharma Limited reports a change in its board or management
In short
Gland Pharma Limited informed the NSE that its Director/KMP/SMP has resigned. In simple terms, the company told the exchange that a senior official is stepping down, which may affect its management lineup.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.